Cholesterol is an essential molecule for cell function.
Our bodies can synthesize cholesterol even if it is not obtained through diet, highlighting its importance.
The body produces cholesterol through a process called endogenous cholesterol production.
Substrates used for cholesterol synthesis include:
Glucose
Fatty acids
Amino acids
Initial step involves converting these substrates into acetyl CoA.
Acetyl CoA converts into HMG-CoA (3-hydroxy-3-methylglutaryl-CoA).
Regulatory Step: HMG-CoA is converted to mevalonate via the enzyme HMG-CoA reductase.
This step is called the rate-limiting step, crucial for regulating cholesterol synthesis.
When cholesterol levels in the cell are sufficient:
Cholesterol inhibits further production by suppressing HMG-CoA reductase.
When cholesterol levels decrease:
Inhibition is lifted, thus accelerating enzyme activity and cholesterol production.
This self-regulatory mechanism allows the body to maintain cholesterol homeostasis effectively.
The liver is a major organ synthesizing cholesterol (800 to 1500 mg/day).
Cholesterol is used to produce bile, which is released in response to food intake and is necessary for digestion.
The liver processes both dietary cholesterol and that which it produces.
Cholesterol cannot be broken down for energy like fatty acids.
The body eliminates excess cholesterol primarily through bile:
Bile composed of both free cholesterol and bile salts regulates cholesterol levels.
Enterohepatic circulation allows the recycling of cholesterol and bile salts back to the liver, with 50% of free cholesterol reabsorbed and 3% of bile acids excreted in feces.
Statins are used to inhibit HMG-CoA reductase, directly lowering cholesterol levels.
Bile salt sequestrants bind bile salts in the gut, preventing reabsorption, encouraging cholesterol use for bile synthesis.
This method is less effective due to the body’s ability to self-regulate cholesterol production in response to increased bile loss.
Proposed by Ancel Keys in the 1960s-1970s, suggesting a correlation between saturated fat intake and cardiovascular disease.
The hypothesis relied on selective data, namely the "Seven Countries Study," which has been critiqued for cherry-picking data supporting the hypothesis.
Critics argue that cholesterol's association with heart disease may be a coincidental correlation rather than a causal link.
Cardiovascular disease is increasingly considered an inflammatory issue, not merely linked to cholesterol.
Studies indicate that the presence of cholesterol in arterial plaque may be a byproduct of an inflammatory response rather than the cause.
Factors initiating inflammation, and thus contributing to atherosclerosis, need to be better understood.
Rising heart disease rates alongside stable saturated fat consumption challenge the direct link suggested in the diet-heart hypothesis.
More recent studies show acknowledgement of the role of other dietary factors, such as vegetable oils.
Historical studies attempting to prove saturated fat as harmful often revealed opposing results, such as Increase in mortality in groups substituting saturated fats with unsaturated fats.
It is important to critically assess scientific studies and the influence of pharmaceutical and dietary biases.
Understanding the role of cholesterol is crucial, not as a villain, but as a necessary component of human biology.